These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Editorial: central nervous system drugs in the treatment of neurological disorders. Samsam M Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):153-7. PubMed ID: 22894608 [No Abstract] [Full Text] [Related]
4. Editorial: Medicinal Chemistry: Neurological and Endocrinological Disorders. Kamal MA Med Chem; 2016; 12(3):202-3. PubMed ID: 27056133 [No Abstract] [Full Text] [Related]
5. Editorial (Thematic Issue: The Activity of Products From Cnidaria: A Therapeutic Tool in Neurological Diseases? Part II). Mariottini GL Cent Nerv Syst Agents Med Chem; 2016; 16(3):165-166. PubMed ID: 28034295 [No Abstract] [Full Text] [Related]
6. Editorial: Current Strategies for Drug Discovery Targeting Neurological Autoimmune Diseases. Skundric DS Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):3. PubMed ID: 29474167 [No Abstract] [Full Text] [Related]
7. Angiogenesis in neurological disorders: a review. Acar G; Tanrıöver G; Demir R Neurol Res; 2012 Sep; 34(7):627-35. PubMed ID: 22889669 [TBL] [Abstract][Full Text] [Related]
9. Modifying protein misfolding. Jones D Nat Rev Drug Discov; 2010 Nov; 9(11):825-7. PubMed ID: 21030987 [No Abstract] [Full Text] [Related]
10. Two Latest Hot Researches in Medicinal Chemistry. Zhou GP; Chou KC Curr Top Med Chem; 2020; 20(4):264-265. PubMed ID: 32238127 [No Abstract] [Full Text] [Related]
11. Immunophilin ligands as a novel treatment of neurological disorders. Herdegan T; Fischer G; Bold BG Trends Pharmacol Sci; 2000 Jan; 21(1):3-5. PubMed ID: 10712163 [No Abstract] [Full Text] [Related]
12. Aquaporin-4, homeostasis, and neurologic disease. Benarroch EE Neurology; 2007 Dec; 69(24):2266-8. PubMed ID: 18071147 [No Abstract] [Full Text] [Related]
13. Microglia--a therapeutic target in neurological diseases and disorders. Kaur C; Ling EA CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):719. PubMed ID: 24047518 [No Abstract] [Full Text] [Related]
14. Editorial: Endocrine Modulators of Neurological Processes: Potential Treatment Targets of Pediatric Neurological Diseases. Ni H; Biagini G; Upadhya D; Capuano A Front Endocrinol (Lausanne); 2021; 12():655290. PubMed ID: 33679621 [No Abstract] [Full Text] [Related]
15. Current Trends for Rationalizing Brain Targeting Nanoparticles in Neurological Disorders (Part-I). Javed MN; Ashraf GM; Barreto GE; Naim MJ Curr Drug Metab; 2020; 21(9):648. PubMed ID: 33327901 [No Abstract] [Full Text] [Related]
16. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal. Kanwar JR; Sun X; Punj V; Sriramoju B; Mohan RR; Zhou SF; Chauhan A; Kanwar RK Nanomedicine; 2012 May; 8(4):399-414. PubMed ID: 21889479 [TBL] [Abstract][Full Text] [Related]
17. Ligand-gated ion channels: new insights into neurological disorders and ligand recognition. Lemoine D; Jiang R; Taly A; Chataigneau T; Specht A; Grutter T Chem Rev; 2012 Dec; 112(12):6285-318. PubMed ID: 22988962 [No Abstract] [Full Text] [Related]
18. The neurobiology of erythropoietin. Sytkowski AJ Cell Mol Neurobiol; 2011 Aug; 31(6):931-7. PubMed ID: 21538117 [No Abstract] [Full Text] [Related]